Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.. Caris Life Sciences has now raised $1.86 billion in capital since 2018.

Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial public offering, aiming to raise up to $423.5 million. The Irving, Texas ...